US Bancorp’s Augmedix, Inc. Common Stock AUGX Stock Holding History
Bought
Maintained
Sold
Other funds holding AUGX
RG
DIV
MAG
AFG
PCM
SC
TC
US Bancorp's AUGX Position: Q1 2022 in Review
US Bancorp sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2022, closing a stake of 1,374 shares — an estimated $4K sold.
US Bancorp first reported a position in AUGX in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 22 funds tracked by Wall St. Rank hold AUGX as of Q1 2022.
- US Bancorp reported no remaining Augmedix, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- US Bancorp sold 1,374 Augmedix, Inc. Common Stock shares in Q1 2022, an estimated $4K.
- US Bancorp first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
- US Bancorp's Augmedix, Inc. Common Stock position peaked at $4K in Q4 2021.
- 22 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2022.
Based on US Bancorp's 13F filing for Q1 2022, filed 11 May 2022.